Bayesian Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-15,197
| Closed | -$207K | – | 918 |
|
|
2021
Q4 | $207K | Buy |
+15,197
| New | +$207K | 0.07% | 318 |
|
|
2021
Q3 | – | Sell |
-14,222
| Closed | -$239K | – | 538 |
|
|
2021
Q2 | $239K | Sell |
14,222
-18,515
| -57% | -$311K | 0.06% | 335 |
|
|
2021
Q1 | $598K | Buy |
32,737
+14,300
| +78% | +$261K | 0.14% | 197 |
|
|
2020
Q4 | $336K | Buy |
18,437
+5,142
| +39% | +$93.7K | 0.09% | 281 |
|
|
2020
Q3 | $237K | Buy |
+13,295
| New | +$237K | 0.06% | 399 |
|
|
2020
Q2 | – | Sell |
-20,282
| Closed | -$308K | – | 774 |
|
|
2020
Q1 | $308K | Buy |
+20,282
| New | +$308K | 0.07% | 447 |
|